Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

LLY Eli Lilly and Co

748,00

1,26 (0,17%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:36:21

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Eli Lilly (NYSE:LLY)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Eli Lilly Charts.

Eli Lilly (NYSE:LLY)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Eli Lilly Charts.

News Eli Lilly and Co

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
Mittwoch 15 Januar 2025 (16 Stunden vor) • PR Newswire (US)

Form 8-K - Current report
Dienstag 14 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance
Dienstag 14 Januar 2025 (2 Tage vor) • PR Newswire (US)

Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program
Montag 13 Januar 2025 (3 Tage vor) • PR Newswire (US)

Lilly to participate in J.P. Morgan Healthcare Conference
Dienstag 7 Januar 2025 (1 Woche vor) • PR Newswire (US)

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Freitag 20 Dezember 2024 (4 Wochen vor) • PR Newswire (US)

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease
Mittwoch 18 Dezember 2024 (4 Wochen vor) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 17 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Weitere Eli Lilly and Co News-Artikel

Euro vs US Dollar

Invesco QQQ Trust Series 1

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen